Stockscreener 앱 받기
4.19
0.24%
-0.00
전일 마감가:
$4.19
열려 있는:
$4.15
하루 거래량:
2,204
Relative Volume:
0.01
시가총액:
$6.58M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-3.6435
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
+0.84%
1개월 성능:
-6.49%
6개월 성능:
-53.57%
1년 성능:
-89.50%
1일 변동 폭
$4.15
$4.15
1주일 범위
$3.83
$4.27
52주 변동 폭
$3.80
$44.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
ACXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
4.15 | 6.54M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.83 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.66 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.80 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
773.34 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
323.54 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
Short interest data insights for Acurx Pharmaceuticals Inc.2025 Historical Comparison & Momentum Based Trading Signals - Newser
Has Acurx Pharmaceuticals Inc. found a price floor2025 Fundamental Recap & Capital Protection Trade Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock poised for growth2025 Volume Leaders & Verified Entry Point Signals - Newser
Sentiment analysis tools applied to Acurx Pharmaceuticals Inc.2025 Biggest Moves & Free Safe Capital Growth Stock Tips - Newser
Does Acurx Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
Applying sector rotation models to Acurx Pharmaceuticals Inc.2025 Momentum Check & Consistent Profit Trading Strategies - Newser
Strategies to average down on Acurx Pharmaceuticals Inc.Quarterly Earnings Report & Weekly Market Pulse Updates - Newser
Is Acurx Pharmaceuticals Inc. trending in predictive chart modelsTrade Volume Report & Verified Entry Point Signals - Newser
Acurx Pharmaceuticals Reports Reduced Losses Amid Ongoing R&D Efforts - MSN
What are the risks of holding Acurx Pharmaceuticals Inc.Weekly Trade Report & Safe Swing Trade Setup Alerts - Lancaster City Council
Published on: 2025-09-09 07:28:35 - Newser
Real time social sentiment graph for Acurx Pharmaceuticals Inc.Quarterly Earnings Report & Technical Entry and Exit Alerts - Newser
How to integrate Acurx Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser
Smart tools for monitoring Acurx Pharmaceuticals Inc.’s price actionJuly 2025 Breakouts & Fast Gain Swing Alerts - Newser
Analyzing recovery setups for Acurx Pharmaceuticals Inc. investors2025 Stock Rankings & Technical Pattern Based Signals - Newser
What MACD signals say about Acurx Pharmaceuticals Inc.Swing Trade & Trade Opportunity Analysis - Newser
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Market Growth Review & Capital Protection Trading Alerts - Newser
What technical models suggest about Acurx Pharmaceuticals Inc.’s comebackBear Alert & Community Consensus Picks - Newser
Visual analytics tools that track Acurx Pharmaceuticals Inc. performanceJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
Will Acurx Pharmaceuticals Inc. rebound enough to break evenQuarterly Trade Review & Capital Efficient Trade Techniques - Newser
Acurx Pharmaceuticals Inc. Trading Near Value Zone — Recovery AheadJobs Report & Risk Controlled Stock Pick Alerts - beatles.ru
Using AI based signals to follow Acurx Pharmaceuticals Inc.Portfolio Return Summary & AI Driven Stock Reports - Newser
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - aberdeennews.com
Trend analysis for Acurx Pharmaceuticals Inc. this weekJuly 2025 Trends & Precise Swing Trade Entry Alerts - Newser
Acurx Pharmaceuticals regains compliance with Nasdaq’s listing rules - MSN
Will Acurx Pharmaceuticals Inc. benefit from macro trendsWeekly Profit Report & Safe Capital Growth Stock Tips - Newser
Will Acurx Pharmaceuticals Inc. outperform the marketAnalyst Upgrade & Growth Oriented Trading Recommendations - Newser
What data driven models say about Acurx Pharmaceuticals Inc.’s futureWatch List & High Accuracy Investment Entry Signals - Newser
Using R and stats models for Acurx Pharmaceuticals Inc. forecastingTrade Entry Report & Consistent Profit Alerts - Newser
What does recent volatility data suggest for Acurx Pharmaceuticals Inc.2025 Big Picture & Weekly High Return Opportunities - Newser
Visual trend scoring systems applied to Acurx Pharmaceuticals Inc.2025 Earnings Impact & Short-Term Trading Opportunity Alerts - Newser
Will Acurx Pharmaceuticals Inc. continue its uptrendJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - Newser
What to do if you’re stuck in Acurx Pharmaceuticals Inc.July 2025 Trends & Real-Time Market Sentiment Alerts - Newser
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acurx Pharmaceuticals Inc 주식 (ACXP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
0.05%
0.51%
자본화:
|
볼륨(24시간):